Clinical Trial Update: Sulodexide in Controlling the Recurrence of Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating sulodexide for preventing recurrence of psoriasis. The study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Sulodexide (sulodexide)

Snippet

Sponsor: Xijing Hospital | Conditions: Psoriasis (PsO), Randomised Controlled Trial | Phase 3 | Status: ENROLLING_BY_INVITATION